Pharmafile Logo

Business Research

- PMLiVE

Mining for results

How one tech firm is working with Big Data

The rating game

Have we gone too far with online healthcare reviews?

- PMLiVE

The reality of real-world evidence

Despite a slow uptake of RWE, there is an increasing trend in the use of healthcare system data to inform clinical practice

Smart connections with a human touch

Simon Young, Director at Blue Latitude Health, discusses how advances in technology are influencing the future of the expert-patient relationship and why healthcare businesses must evaluate how best to support...

Blue Latitude Health

- PMLiVE

The digital race: Eight ways to get up-to-speed

The festive season is over, so why does analysis of pharma’s digital progress feel like a Christmas repeat of Groundhog Day? Here are eight ideas to stop next year feeling like...

- PMLiVE

Real-world evidence

Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

Patient-centred care innovation in dementia: a conversation with Neil Maiden

Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators...

Blue Latitude Health

- PMLiVE

Merck forges cancer-focused big data alliance with Palantir

Plans to develop a collaborative analytics platform to accelerate research and improve outcomes

Challenging times

It’s not an easy time for pharma, but there are opportunities for those companies that are willing to be true game changers

- PMLiVE

Don’t you forget about me

Are we neglecting the needs of those on the fringes of digital?

- PMLiVE

2017 Trends in healthcare – how advances in technology are influencing the expert-patient relationship

In the 2017 trends edition of Perspective magazine, we explore how advances in technology are influencing the future of the expert-patient relationship and the role healthcare businesses can take in...

Blue Latitude Health

- PMLiVE

Neurodegenerative disorders market set to reach $45bn by 2022

But shake-up expected from flurry of new approvals and patent expirations

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links